Head of Clinical Trials
Holder of a State Diploma in Pharmacy and a DES specialized studies diploma in Pharmaceutical Innovation and Research, Grégoire has extensive expertise in pharmacology, toxicology, pharmacokinetics and analytical chemistry. Formerly head of the chromatographic platform and biologist in the anti-infectives assay department at Saint-Joseph hospital in Paris, he also taught pharmacokinetics in the Clinical Pharmacy Department at Paris-Sud University. He joined Cerba in 2019 in the pharmaco-toxicology department, before taking up the position of clinical trials manager in 2022. He notably played a major role in setting up an analytical chemistry laboratory to develop a method for the biometric monitoring of population exposure to Chlordecone in Martinique, thus helping implement the subsequent epidemiological surveillance orchestrated by the Martinique health services. He is also behind the introduction of innovative panels for quantifying exposure to two classes of endocrine disruptors, bisphenols and phthalates, making Cerba the first medical biology laboratory in France to offer this monitoring tool to the populations concerned.